California researchers found that analyzing cell-bound complement activation products (CB-CAPs) ably distinguishes between systemic lupus erythematosus (SLE) and fibromyalgia (FM), and complements current test methods. Whereas fibromyalgia and lupus might share non-specific symptoms, the two diseases have a radically different underlying cause. Lupus is primarily an inflammatory autoimmune condition, while fibromyalgia is not, and the treatment and prognosis differ accordingly. … Continue reading Fibromyalgia Distinguished from Lupus with 100% Specificity Using New Test